Endometrial Squamous Cell Carcinoma
6 clinical trials · Condition
◉ Watch Endometrial Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer (NCT01642082) | Gynecologic Oncology Group | 2012-09-01 |
| Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer (NCT01225887) | Gynecologic Oncology Group | 2011-10-01 |
| Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer (NCT01440998) | National Cancer Institute (NCI) | 2011-09-20 |
| Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer (NCT00492778) | GOG Foundation | 2008-02-25 |
| Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer (NCT00575952) | Gynecologic Oncology Group | 2008-01-17 |
Track Endometrial Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.